| Literature DB >> 28620285 |
Jana Murínová1, Nataša Hlaváčová2, Magdaléna Chmelová2, Igor Riečanský1,3.
Abstract
There is evidence that development and maintenance of neural connections are disrupted in major mental disorders, which indicates that neurotrophic factors could play a critical role in their pathogenesis. Stress is a well-established risk factor for psychopathology and recent research suggests that disrupted signaling via brain-derived neurotrophic factor (BDNF) may be involved in mediating the negative effects of stress on the brain. Social isolation of rats elicits chronic stress and is widely used as an animal model of mental disorders such as schizophrenia and depression. We carried out a systematic search of published studies to review current evidence for an altered expression of BDNF in the brain of rats reared or housed in social isolation. Across all age groups (post-weaning, adolescent, adult), majority of the identified studies (16/21) reported a decreased expression of BDNF in the hippocampus. There are far less published data on BDNF expression in other brain regions. Data are also scarce to assess the behavioral changes as a function of BDNF expression, but the downregulation of BDNF seems to be associated with increased anxiety-like symptoms. The reviewed data generally support the putative involvement of BDNF in the pathogenesis of stress-related mental illness. However, the mechanisms linking chronic social isolation, BDNF expression and the elicited behavioral alterations are currently unknown.Entities:
Keywords: animal models; chronic stress; depression; isolation rearing; mental disorders; neural plasticity; neurotrophic factors; schizophrenia
Year: 2017 PMID: 28620285 PMCID: PMC5449742 DOI: 10.3389/fnbeh.2017.00101
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
Figure 1Processing steps that followed the primary search.
Summary of results of the studies that employed rearing or housing rats in isolation.
| Post-weaning | 4 | SD ♀, ♂ | = BDNF protein expression in mPFC in both ♂and ♀ | ↑ Social interaction with a novel conspecific | Wall et al., |
| Post-weaning | 4.3 | SD ♂ | ↓ BDNF protein expression in the hippocampus | ↑ Spatial learning (↓ escape latency in MWM) | Pisu et al., |
| Post-weaning | 4.3 | SD ♂ | ↓ BDNF protein expression in the hippocampus | ↑ Anxiety (↓ time in open arms of EPM task) | Pisu et al., |
| Post-weaning | 4.3 | SD ♀, ♂ | ↓ BDNF protein expression in the hippocampus in ♂ | ↑ Anhedonia in ♂(↓ sucrose intake) | Pisu et al., |
| Post-weaning | 5 | SD ♂ | = BDNF protein levels in the frontal cortex, striatum, hippocampus and cerebellum | = Anxiety (time spent in open arms of EPM) | Simpson et al., |
| Post-weaning | 5.7 | L-E ♂ | ↓ BDNF protein expression in the central amygdala and the hippocampus | = Anxiety (time spent in open arms of EPM) | Ravenelle et al., |
| Post-weaning | 6 | SD ♀, ♂ | = BDNF protein levels in the frontal cortex, hippocampus, occipital cortex and cerebellar vermis in both ♂and ♀ | = NGF protein levels in the frontal cortex, hippocampus, occipital cortex and cerebellar vermis | Parks et al., |
| Post-weaning | 8 | SD ♂ | ↓ BDNF protein level in the striatum | ↓ Prepulse inhibition of the startle reflex | Uys et al., |
| Post-weaning | 12 | F-H ♂ | ↓ BDNF mRNA expression in the basolateral amygdala and dentate gyrus | ↑ DA D2 receptor binding in NAc, the basolateral amygdala, central nucleus of the amygdala and the substantia nigra | Djouma et al., |
| Post-weaning | 2 (+ next 3 weeks of social housing) | SD ♂ | ↓ BDNF protein expression in the hippocampus and NAc | Impaired reversal learning in MWM | Han et al., |
| Post-weaning | 2 (+ next 3 weeks of social housing) | SD ♂ | ↓ BDNF mRNA and protein expression in the hippocampus | ↓ H3 acetylation of BDNF gene in the hippocampus | Li et al., |
| Post-weaning | 2 (+ next 4 weeks of social housing) | SD ♂ | ↑ BDNF protein expression in PFC and the hippocampus | Meng et al., | |
| Adolescent | 6, 10 | W ♂ | = BDNF protein levels in the hippocampus after 6 weeks of isolation | ↑ Anxiety (↑ latency to feed in NSFT) | Evans et al., |
| Adolescent | 9 | W ♂ | ↓ BDNF protein levels in the hippocampus | = Locomotion (number of line crossing in OF) | Sun et al., |
| Adolescent | 2 (+ next 2 weeks of social housing) | W ♂ | ↑ BDNF protein levels in mPFC | Deficit in latent inhibition | Shao et al., |
| Adolescent | 2.9 (+ next 2.9 weeks of social housing) | SD ♀, ♂ | ↓ BDNF mRNA expression in CA3 of the hippocampus in ♀ | ↓ Anxiety (↑ time spent in the open arms of EPM) in ♂ | Weintraub et al., |
| Adulthood | 3 | W ♂ | ↓ BDNF mRNA expression in the hippocampus | ↓ GR mRNA expression in the hippocampus and PFC | Adzic et al., |
| Adulthood | 5 | FRL, FSL ♂ | = BDNF mRNA expression in the hippocampus | = Locomotion (distance moved in OF) | Fischer et al., |
| Adulthood | 6 | SD ♂ | ↓ BDNF protein levels in the hippocampus | ↑ Anhedonia (↓ sucrose intake) | Ma et al., |
| Adulthood | 8 | SD ♂ | ↓ BDNF expression in the dorsal hippocampus | ↓ Synaptophysin expression in the PFC, ventral and dorsal hippocampus, and caudal putamen | Gong et al., |
| Adulthood | 8 | SD ♂ | ↓ BDNF protein levels in the hippocampus | = Basal plasma corticosterone levels | Scaccianoce et al., |
SD, Sprague Dawley; L-E, Long Evans; F-H, Fawn-Hooded; W, Wistar; FRL, Flinders Resistant Line; FSL, Flinders Sensitive Line.
♂, male; ♀, female; ↓, decreased; ↑, increased; =, no change.
5HIAA, 5-hydroxyindoleacetic acid; 5HT, 5-hydroxytryptamine (serotonin); ACTH, adrenocorticotropic hormone; ALLO, allopregnanolone; Arc, activity-regulated cytoskeleton-associated protein; AVP, arginine vasopressin; BDNF, brain-derived neurotrophic factor; Cdk5, cyclin-dependent kinase 5; CRH, corticotropin releasing hormone; CRHR1, corticotropin releasing hormone type 1 receptor; DA, dopamine; EPM, elevated plus maze; FST, forced swimming test; GR, glucocorticoid receptor; GRS232, glucocorticoid receptor phosphorylation at serine 232; H3, histone protein 3; JNK, c-jun N-terminal kinase; mPFC, medial prefrontal cortex; mRNA, messenger RNA; MWM, Morris water maze; NA, noradrenaline; NAc, nucleus accumbens; NGF, nerve growth factor; NORT, novel object recognition test; NSFT, novelty suppressed feeding test; NT-3, neurotrophin-3; OF, open field; PFC, prefrontal cortex; pS473-AKT, serine-473-phosphorylated Akt (active form); pS9-GSK-3β, serine-9-phosphorylated GSK-3β (inactive form); PSD93, post-synaptic density protein of 93 kDa; PVN, paraventricular nucleus; TrkB, tyrosine receptor kinase B.